Assistance Listing 93.365
Sickle Cell Treatment Demonstration Program
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · Health Resources and Services Administration
Assistance Listing 93.365, “Sickle Cell Treatment Demonstration Program,” is a federal program administered by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. It provides grant assistance. GrantsJunction currently tracks 0 open, 0 forecasted and 0 closed opportunities under this listing. The agency reported $5.78M in obligations for fiscal year 2025.
Program objective
The objectives of this project is to support the development and establishment of systemic mechanisms to improve the prevention and treatment of sickle cell disease complications, including the coordination of service delivery for individuals with sickle cell disease; genetic counseling and testing; bundling of technical services related to the prevention and treatment of sickle cell disease; training of health professionals; and identifying and establishing efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with Sickle Cell Disease as authorized in 42 USC Section 300b-5(b) (Section 1106(b) of the Public Health Service Act).
As published in the SAM.gov Assistance Listing.
Current opportunities under 93.365
No open or forecasted opportunities are currently posted under this listing. Programs often post notices on an annual cycle — see recently closed opportunities below for timing.
Eligible applicants (program level)
- Nonprofit Organization
- Other
Eligible entities include, Federally-qualified health center, as defined in section 1905(10(2)(B) of the Social Security Act (42 U.S.C. 1396d(10(2)(B), nonprofit hospital or clinic, or university health center that provides primary health care, that: (1) has a collaborative agreement with a community-based Sickle Cell Disease organization or a nonprofit entity with experience in working with individuals who have Sickle Cell Disease; and (2) demonstrates that either the Federally-qualified health center, the nonprofit hospital or clinic, the university health center, the community-based Sickle Cell Disease organization or the Sickle Cell Disease experts who serve as consultants to the project have at least 5 years of experience in working with individuals who have Sickle Cell Disease.
Intended beneficiaries: Other, Health Professional and Unrestricted by Individual Type.
Program-level eligibility from SAM.gov. Each funding notice sets its own requirements.
Reported obligations by fiscal year
Historical data · not a predictionRange and average of financial assistance (from the listing): FY 23 act. $1,090,000-$1,340,000; $1,190,000 FY 24 act . $1,024,000 -$1,150,000; $1,274,000 FY 25 est. $900,000-$1,150,000; $1,000,000
Source: SAM.gov Assistance Listing 93.365. Hatched bars are agency estimates. These totals do not indicate approval rates.Frequently asked questions
What is ALN 93.365?
93.365 is the Assistance Listing Number for “Sickle Cell Treatment Demonstration Program.” Assistance Listing Numbers (formerly CFDA numbers) identify federal assistance programs; individual grant opportunities reference the listing they are funded under.
Who can apply under ALN 93.365?
The SAM.gov listing names these applicant types: Nonprofit Organization and Other. Each funding notice under the program sets its own eligibility, so check the specific opportunity.
How much funding does 93.365 provide?
The agency reported $5,775,000 in obligations for FY2025 in the SAM.gov Assistance Listing. These are program-wide totals reported by the agency, not a prediction of future awards.